Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Jobs with greater risk for COVID-19 exposure have high number of Black or Hispanic workers

Black and Hispanic people experience a higher risk for COVID-19 and severe illness, influenced by factors such as discrimination, housing, and healthcare access and utilization.

11 Mar 2021

KHN’s ‘What the Health?’: Expanding the ACA in an unpredicted way

For the first time since its enactment in 2010, the Affordable Care Act is slated for major benefit expansions, courtesy of the covid relief bill approved by Congress this week. But the changes are only temporary, so the measure also tees up a fight to make them permanent.

11 Mar 2021

People previously infected with SARS-CoV-2 may achieve immunity after one mRNA vaccine dose, finds study

A team of researchers led by Thomas W. McDade of Northwestern University suggests people who were previously infected with SARS-CoV-2, the causative agent of COVID-19, may require only one dose of the mRNA vaccine to obtain immunity.

11 Mar 2021

Study finds limited association between vitamin D and improved COVID-19 outcomes

New research shows a lack of an association between Vitamin D deficiency and the number of COVID-19 cases, recoveries, or mortality rates in European countries.

11 Mar 2021

High obesity rates in Southern states magnify Covid threat

In January, as Mississippi health officials planned for their incoming shipments of covid-19 vaccine, they assessed the state's most vulnerable: health care workers, of course, and elderly people in nursing homes.

11 Mar 2021

SARS-CoV-2 can infect blood monocytes and trigger inflammation, finds study

Researchers found about 10% of blood monocytes in coronavirus disease 2019 (COVID-19) patients are infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). These monocytes then die, leading to the release of cytokines – a feature associated with severe and critical COVID-19.

11 Mar 2021

Could an “ACE2 Triple Decoy” be an alternative approach to neutralizing SARS-CoV-2?

A team of scientists from the USA recently developed a recombinant “Angiotensin converting enzyme 2 (ACE2) Triple Decoy” that can trap SARS-CoV-2 and prevent its propagation inside the host cell.

11 Mar 2021

Promega launches XpressAmp™ Direct Amplification Reagents

Promega Corporation has released XpressAmp™ Direct Amplification Reagents that facilitate RNA extraction-free sample preparation that is automation-friendly.

From Promega Corporation 11 Mar 2021

Is a single mRNA COVID-19 vaccine dose enough for recovered individuals?

A new study deals with the evaluation of adaptive immune response to COVID-19 vaccination in candidates who have recovered from SARS-CoV-2 infection.

11 Mar 2021

Researchers develop assay for qualitative assessment of SARS-CoV-2 neutralizing antibodies

To address the need for a high-quality neutralization assay against SARS-CoV-2, researchers from the NIAID modified and optimized a previously established fluorescence reduction neutralization assay (FRNA) to provide a quantitative assessment of a large number of infected cells through the use of a high-content imaging system.

11 Mar 2021

Nanobody works against all SARS-CoV-2 variants of concern in animal model

Researchers based in Belgium have developed a new antibody drug that is highly successful at neutralizing coronavirus disease 2019 (COVID-19) in Syrian hamsters. The new biologic was administered to the rodents and was found to be equally successful at neutralizing the original severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain, and also the new mutant variants, such as the South African and UK strains.

11 Mar 2021

Believing in one’s own capabilities boosts personal resilience, shows study

The unpredictable nature of life during the coronavirus pandemic is particularly challenging for many people. Not everyone can cope equally well with the uncertainty and loss of control.

11 Mar 2021

Brazil COVID variant 2.5 times more transmissible than ancestral strain

In early January 2021, a new variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified from travelers returning from Brazil. This variant, referred to as “P.1”, likely emerged in early-to-late November 2020, and subsequently spread throughout Manaus, the state capital of Amazonas, Brazil, over the following December.

11 Mar 2021

SARS-CoV-2 spike S1 subunit induces hypercoagulability

The vascular complications of the condition include a range of various coagulopathies that cause bleeding and thrombocytopenia or a hypercoagulable state. A new preprint research paper posted to the medRxiv server describes the role of a fibrinogen-related protein in inducing these clinical features of COVID-19.

10 Mar 2021

Study assesses COVID-19 policy differences between GOP- and Democrat-led states

The per-capita rates of new COVID-19 cases and COVID-19 deaths were higher in states with Democrat governors in the first months of the pandemic last year, but became much higher in states with Republican governors by mid-summer and through 2020, possibly reflecting COVID-19 policy differences between GOP- and Democrat-led states, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health and the Medical University of South Carolina.

10 Mar 2021

TraCK study says schoolchildren unlikely to transmit SARS-CoV-2

An interesting new preprint research paper posted to the medRxiv* server reports there is little evidence to suggest the rapid transmission of the virus among school children while attending school.

10 Mar 2021

Danish study on the efficacy of Pfizer/BioNTech SARS-CoV-2 vaccine after first and second dose

As the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues, many countries have rolled out vaccines against the virus. In an encouraging preprint research paper posted to the medRxiv* server, scientists report on the vaccine efficacy in the Danish vaccination program.

10 Mar 2021

South African SARS-CoV-2 variant most problematic for BNT-162b2 vaccine

Researchers from Germany and the US investigated the efficacy of neutralizing antibodies against newer variants using serum and saliva samples obtained from groups of infected, vaccinated (with Pfizer BNT-162b2), and uninfected individuals. The researchers started this study to uncover vaccine-induced immune response and show the efficiency of antibody binding and neutralization in SARS-CoV-2 variants.

10 Mar 2021

Study confirms COVID-19 vaccine rollout decreasing disease incidence across USA

By comparing vaccination rates in 580 counties across the United States with the corresponding coronavirus disease (COVID-19) incidence rates, a recent study currently available on the medRxiv preprint server finds that cumulative county-level vaccination rates are significantly associated with a concomitant fall in the incidence of COVID-19.

10 Mar 2021

Newly-discovered bat coronavirus 94.5% identical to SARS-CoV-2

Researchers in China and Australia have reported the discovery of novel bat coronaviruses that further reveal the diversity and complex evolutionary history of these viruses.

10 Mar 2021

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Jobs with greater risk for COVID-19 exposure have high number of Black or Hispanic workers

KHN’s ‘What the Health?’: Expanding the ACA in an unpredicted way

People previously infected with SARS-CoV-2 may achieve immunity after one mRNA vaccine dose, finds study

Study finds limited association between vitamin D and improved COVID-19 outcomes

High obesity rates in Southern states magnify Covid threat

SARS-CoV-2 can infect blood monocytes and trigger inflammation, finds study

Could an “ACE2 Triple Decoy” be an alternative approach to neutralizing SARS-CoV-2?

Promega launches XpressAmp™ Direct Amplification Reagents

Is a single mRNA COVID-19 vaccine dose enough for recovered individuals?

Researchers develop assay for qualitative assessment of SARS-CoV-2 neutralizing antibodies

Nanobody works against all SARS-CoV-2 variants of concern in animal model

Believing in one’s own capabilities boosts personal resilience, shows study

Brazil COVID variant 2.5 times more transmissible than ancestral strain

SARS-CoV-2 spike S1 subunit induces hypercoagulability

Study assesses COVID-19 policy differences between GOP- and Democrat-led states

TraCK study says schoolchildren unlikely to transmit SARS-CoV-2

Danish study on the efficacy of Pfizer/BioNTech SARS-CoV-2 vaccine after first and second dose

South African SARS-CoV-2 variant most problematic for BNT-162b2 vaccine

Study confirms COVID-19 vaccine rollout decreasing disease incidence across USA

Newly-discovered bat coronavirus 94.5% identical to SARS-CoV-2

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Newsletters you may be interested in